ZOLOFT Safety Questions, ZOLOFT Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about ZOLOFT. Our extensive database of ZOLOFT adverse events and ZOLOFT warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about ZOLOFT

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




ZOLOFT Safety Reports

Total ZOLOFT reports: 700.
ZOLOFT FDA safety alerts: 2002 2004 2005 .
Reported deaths: 50    Reported hospitalizations: 198.
Take ZOLOFT Side Effects Survey or Share Your ZOLOFT Story. ZOLOFT Usage.

< Previous  Showing 151-225 of 700 Next >

Physician from JAPAN reported ZOLOFT problem on Apr 10, 2007. Male patient, 65 years of age, was diagnosed with depression and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: disturbance in attention, road traffic accident. ZOLOFT dosage: DAILY DOSE:100MG. During the same period patient was treated with TETRAMIDE, ISOMYTAL, DORAL. Patient recovered.

ZOLOFT problem was reported by a Physician from UNITED STATES on Apr 11, 2007. Female patient, weighting 170.0 lb, was diagnosed with stress, mood swings, hot flush, menopause and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: bereavement reaction, blood cholesterol increased, bone giant cell tumour, cognitive disorder, crying, dehydration, diarrhoea, intestinal functional disorder, osteoarthritis. ZOLOFT dosage: unknown. During the same period patient was treated with SERTRALINE, NAPROXEN, GLUCOSAMINE, VITAMIN D. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZOLOFT problem on Apr 19, 2007. Female patient, 27 years of age, weighting 186.0 lb, was diagnosed with anxiety, depression and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: depression, feeling abnormal, hypersomnia. ZOLOFT dosage: 200MG 2 100MG TAB/DAY PO. Patient recovered.

ZOLOFT problem was reported by a Physician from UNITED STATES on Apr 13, 2007. Female patient, 90 years of age, was diagnosed with panic attack, depression and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: confusion postoperative, fall, nerve injury, spinal compression fracture. ZOLOFT dosage: unknown. During the same period patient was treated with HYDROCODONE. Patient recovered.

Physician from UNITED STATES reported ZOLOFT problem on Apr 19, 2007. Male patient was diagnosed with depression, panic disorder and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: anxiety, condition aggravated, panic disorder. ZOLOFT dosage: 150 MG Q AM. Patient recovered.

ZOLOFT problem was reported by a Physician from UNITED STATES on Apr 17, 2007. Female patient, 37 years of age, weighting 170.0 lb, was diagnosed with major depression and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: dizziness, headache. ZOLOFT dosage: 50 MG ONC DAILY ORAL. Patient recovered.

Physician from SWITZERLAND reported ZOLOFT problem on Apr 16, 2007. Male patient, 83 years of age, was diagnosed with depression, delirium, dementia, dysthymic disorder, cyclothymic disorder, dementia alzheimer's type and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: myoclonus. ZOLOFT dosage: unknown. During the same period patient was treated with CLOZAPINE, TRITTICO, NEURONTIN, MEMANTINE. Patient recovered.

ZOLOFT problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 18, 2007. Female patient, weighting 130.1 lb, was diagnosed with obsessive-compulsive disorder, abnormal behaviour and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: dyskinesia, energy increased, mania. ZOLOFT dosage: unknown. During the same period patient was treated with CLONIDINE, SEROQUEL, LAMICTAL, STRATTERA. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported ZOLOFT problem on Apr 17, 2007. Male patient was diagnosed with depression, insomnia and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: disturbance in attention, road traffic accident. ZOLOFT dosage: DAILY DOSE:100MG. During the same period patient was treated with TETRAMIDE, DORAL, ISOMYTAL, DOGMATYL, LIPOVAS, METLIGINE, DEPAS. Patient recovered.

ZOLOFT problem was reported by a Physician from JAPAN on Apr 17, 2007. Female patient, 48 years of age, was diagnosed with depression and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: eosinophilic pneumonia. ZOLOFT dosage: DAILY DOSE:150MG. During the same period patient was treated with MYSLEE, DEPAS. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZOLOFT problem on Mar 12, 2007. Female patient was diagnosed with insomnia and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: accidental overdose, amnesia, coma, eating disorder, sleep talking, sleep walking. ZOLOFT dosage: unknown. During the same period patient was treated with AMBIEN. Patient was hospitalized. Patient recovered.

ZOLOFT problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 18, 2007. Female patient, 87 years of age, weighting 100.1 lb, was diagnosed with depression, metabolic disorder and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: asthenia, feeling abnormal, hyperhidrosis, irritability, pruritus, sleep disorder, weight decreased. ZOLOFT dosage: DAILY DOSE:10MG. During the same period patient was treated with INDERAL, AMBIEN, CALTRATE, KAOPECTATE. Patient recovered.

Consumer or non-health professional from reported ZOLOFT problem on Apr 19, 2007. Male patient, weighting 172.0 lb, was diagnosed with depression and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: anxiety, chest pain, hyperhidrosis, throat tightness. ZOLOFT dosage: unknown. During the same period patient was treated with LORAZEPAM, VITAMINS. Patient recovered.

ZOLOFT problem was reported by a Physician from UNITED STATES on Apr 25, 2007. Male patient, 14 years of age, weighting 186.0 lb, was diagnosed with affective disorder, intermittent explosive disorder and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: affect lability, agitation, anger. ZOLOFT dosage: 150 MG PO QD. During the same period patient was treated with LAMICTAL, GEODON. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZOLOFT problem on Mar 12, 2007. Female patient was diagnosed with insomnia and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: amnesia, binge eating, facial bones fracture, fall. ZOLOFT dosage: unknown. During the same period patient was treated with WELLBUTRIN, FOSAMAX, AMBIEN. Patient recovered.

ZOLOFT problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 12, 2007. Male patient was diagnosed with insomnia and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: amnesia, intentional overdose, libido decreased, road traffic accident, shoplifting, sleep apnoea syndrome, unresponsive to stimuli. ZOLOFT dosage: unknown. During the same period patient was treated with AMBIEN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZOLOFT problem on Apr 18, 2007. Female patient, child 12 years of age, was diagnosed with anxiety and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: agitation, akathisia, anxiety, completed suicide, confusional state, haemodynamic instability, hallucination. ZOLOFT dosage: unknown. During the same period patient was treated with VERSED, CHARCOAL, ATIVAN. Patient died on 01/10/2004.

ZOLOFT problem was reported by a Physician from CANADA on Apr 19, 2007. Male patient was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: congenital absence of bile ducts, nausea. ZOLOFT dosage: DAILY DOSE:100MG. During the same period patient was treated with DICLECTIN. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported ZOLOFT problem on Apr 23, 2007. Male patient, 30 years of age, was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: alcohol poisoning, hepatic function abnormal, insomnia. ZOLOFT dosage: DAILY DOSE:50MG. During the same period patient was treated with ROHYPNOL, VEGETAMIN, DIAZEPAM. Patient died on 04/14/2007.

ZOLOFT problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 23, 2007. Female patient, weighting 117.9 lb, was diagnosed with anxiety, depression and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: anxiety, infection, nausea, nervousness, ulcer. ZOLOFT dosage: unknown. During the same period patient was treated with KLONOPIN, PRILOSEC. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZOLOFT problem on Apr 23, 2007. Female patient, weighting 200.0 lb, was diagnosed with depression and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: diplopia, eye movement disorder, gait disturbance, nystagmus, vision blurred. ZOLOFT dosage: unknown. During the same period patient was treated with LAMICTAL. Patient recovered.

ZOLOFT problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 27, 2007. Male patient was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: back injury, back pain, dyspnoea, myocardial infarction. ZOLOFT dosage: DAILY DOSE:75MG. During the same period patient was treated with CHANTIX, ACETYLSALICYLIC ACID SRT, VITAMINS. Patient recovered.

Physician from GERMANY reported ZOLOFT problem on Apr 27, 2007. Male patient, weighting 149.9 lb, was diagnosed with depression and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: dizziness, gait disturbance, paraesthesia. ZOLOFT dosage: unknown. Patient recovered.

ZOLOFT problem was reported by a Consumer or non-health professional from UNITED STATES on May 01, 2007. Female patient, 30 years of age, weighting 160.0 lb, was diagnosed with anxiety and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: asthenia, diarrhoea, dysphemia, fatigue, feeling abnormal, gait disturbance, speech disorder. ZOLOFT dosage: 50MG. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZOLOFT problem on Apr 25, 2007. Female patient, weighting 200.0 lb, was diagnosed with depression and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: anxiety, depression, hypersensitivity, hypertension, malaise, pneumonia. ZOLOFT dosage: unknown. During the same period patient was treated with CHANTIX, PAXIL, NICOTINE, EFFEXOR, SYNTHROID, MOMETASONE FUROATE, SPIRIVA, XANAX. Patient was hospitalized. Patient recovered.

ZOLOFT problem was reported by a Consumer or non-health professional from BRAZIL on Apr 28, 2007. Female patient was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: foetal growth retardation. ZOLOFT dosage: DAILY DOSE:75MG. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZOLOFT problem on May 03, 2007. Female patient, 28 years of age, weighting 115.0 lb, was diagnosed with post-traumatic stress disorder, postpartum depression and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: aggression, anxiety, balance disorder, confusional state, coordination abnormal, diarrhoea. ZOLOFT dosage: 100MGS 1 PER DAY PO. Patient recovered.

ZOLOFT problem was reported by a Consumer or non-health professional from UNITED STATES on May 01, 2007. Female patient, weighting 138.0 lb, was diagnosed with depression, anxiety, obsessive-compulsive disorder and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: anxiety, depression, obsessive-compulsive disorder. ZOLOFT dosage: DAILY DOSE:50MG. Patient recovered.

Physician from UNITED STATES reported ZOLOFT problem on May 08, 2007. Male patient, 23 years of age, weighting 140.0 lb, was diagnosed with anxiety and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: anhedonia, blunted affect, disturbance in attention, disturbance in sexual arousal, libido decreased, mental impairment, sexual dysfunction. ZOLOFT dosage: 1 TABLET -50 MG- QD PO. Patient recovered.

ZOLOFT problem was reported by a Physician from AUSTRALIA on May 02, 2007. Female patient was diagnosed with anxiety, panic attack and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: anger, anxiety, diarrhoea, fear, fear of disease, panic attack, self-injurious ideation. ZOLOFT dosage: DAILY DOSE:100MG. During the same period patient was treated with VALIUM, DIAZEPAM. Patient recovered.

Physician from UNITED STATES reported ZOLOFT problem on May 02, 2007. Female patient, weighting 160.1 lb, was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: anxiety, obsessive-compulsive disorder, rash. ZOLOFT dosage: unknown. During the same period patient was treated with WELLBUTRIN. Patient recovered.

ZOLOFT problem was reported by a Consumer or non-health professional from UNITED STATES on May 07, 2007. Male patient, weighting 265.0 lb, was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: anxiety, shoulder operation. ZOLOFT dosage: unknown. During the same period patient was treated with CHANTIX, SEROQUEL, WELLBUTRIN. Patient recovered.

Health Professional from UNITED STATES reported ZOLOFT problem on May 09, 2007. Female patient, weighting 230.0 lb, was diagnosed with depression and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: depression, mood altered. ZOLOFT dosage: 100MG QD PO. Patient recovered.

ZOLOFT problem was reported by a Health Professional from UNITED STATES on May 09, 2007. Female patient, 85 years of age, weighting 125.0 lb, was diagnosed with depression and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, delusion, dementia alzheimer's type, disorientation, flight of ideas, incoherent, libido disorder, mania, obsessive thoughts. ZOLOFT dosage: 50MG DAILY PO. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZOLOFT problem on May 08, 2007. Female patient, weighting 250.0 lb, was diagnosed with depression and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: crying, emotional disorder, pain, psoriasis, thermal burn. ZOLOFT dosage: unknown. During the same period patient was treated with ETANERCEPT. Patient recovered.

ZOLOFT problem was reported by a Physician from JAPAN on May 09, 2007. Female patient, 48 years of age, was diagnosed with depression and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: eosinophilic pneumonia. ZOLOFT dosage: DAILY DOSE:150MG. During the same period patient was treated with MYSLEE, DEPAS. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported ZOLOFT problem on May 10, 2007. Female patient, weighting 115.1 lb, was diagnosed with depression and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: back pain, headache, muscle twitching, myalgia, myoclonic epilepsy, pyrexia, white blood cell count increased. ZOLOFT dosage: unknown. During the same period patient was treated with ALCOHOL, YASMIN, FAMVIR. Patient recovered.

ZOLOFT problem was reported by a Physician from JAPAN on May 14, 2007. Female patient, 70 years of age, was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: akathisia. ZOLOFT dosage: DAILY DOSE:50MG. Patient died.

Consumer or non-health professional from UNITED STATES reported ZOLOFT problem on May 17, 2007. Female patient, 14 years of age, weighting 160.0 lb, was diagnosed with bipolar i disorder and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: crying, fear, feeling abnormal, nightmare. ZOLOFT dosage: 50MG 1X/DAILY ORALLY. Patient recovered.

ZOLOFT problem was reported by a Physician from SWEDEN on May 15, 2007. Female patient, 65 years of age, was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: dyspnoea, obstruction. ZOLOFT dosage: unknown. During the same period patient was treated with MIRTAZAPINE. Patient recovered.

Physician from CHINA reported ZOLOFT problem on May 14, 2007. Female patient, 65 years of age, was diagnosed with depression and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased, white blood cell count increased. ZOLOFT dosage: unknown. Patient recovered.

ZOLOFT problem was reported by a Physician from JAPAN on May 14, 2007. Female patient, 60 years of age, was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: akathisia. ZOLOFT dosage: DAILY DOSE:50MG. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZOLOFT problem on May 23, 2007. Male patient, weighting 236.0 lb, was diagnosed with depression and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: agitation, bradykinesia, cardiac pacemaker insertion, depression, disorientation, dysarthria, headache, lethargy. ZOLOFT dosage: unknown. Patient recovered.

ZOLOFT problem was reported by a Physician from AUSTRALIA on May 15, 2007. Female patient, 15 years of age, was diagnosed with attention deficit/hyperactivity disorder, mental impairment and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, pancreatitis. ZOLOFT dosage: 50 MG, EACH MORNING. During the same period patient was treated with CATAPRES, STRATTERA. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported ZOLOFT problem on May 16, 2007. Female patient, weighting 134.0 lb, was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: cataract, glaucoma. ZOLOFT dosage: unknown. During the same period patient was treated with ZYPREXA. Patient recovered.

ZOLOFT problem was reported by a Physician from JAPAN on May 18, 2007. Female patient, 55 years of age, was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: idiopathic thrombocytopenic purpura. ZOLOFT dosage: DAILY DOSE:50MG. Patient recovered.

Pharmacist from UNITED STATES reported ZOLOFT problem on May 21, 2007. Male patient, 25 years of age, weighting 140.0 lb, was diagnosed with insomnia and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, amnesia, eating disorder, hallucination, road traffic accident, skin laceration, sleep walking, weight increased. ZOLOFT dosage: unknown. During the same period patient was treated with AMBIEN, ADDERALL. Patient recovered.

ZOLOFT problem was reported by a Physician from JAPAN on May 25, 2007. Male patient, 40 years of age, was diagnosed with bipolar i disorder and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: anxiety, irritability, suicidal ideation. ZOLOFT dosage: DAILY DOSE:75MG. During the same period patient was treated with LIMAS, PAXIL. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported ZOLOFT problem on May 25, 2007. Female patient, 21 years of age, weighting 243.8 lb, was diagnosed with attention deficit/hyperactivity disorder, bipolar i disorder, panic disorder and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: depressive symptom. ZOLOFT dosage: ZOLOFT 100MG(2) TABS DAILY (PO). Patient recovered.

ZOLOFT problem was reported by a Consumer or non-health professional from SWEDEN on May 22, 2007. Female patient, 41 years of age, was diagnosed with depression, fatigue and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: platelet count increased, uterine inflammation. ZOLOFT dosage: unknown. During the same period patient was treated with ZOLPIDEM. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZOLOFT problem on May 29, 2007. Male patient, 38 years of age, weighting 195.0 lb, was diagnosed with stress and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: decreased interest, ejaculation failure, hallucination, insomnia, libido decreased, paraesthesia, partner stress, tinnitus. ZOLOFT dosage: unknown. During the same period patient was treated with FLUXIFINE. Patient recovered.

ZOLOFT problem was reported by a Pharmacist from UNITED STATES on May 24, 2007. Female patient, 25 years of age, was diagnosed with depression, migraine and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: dry eye, keratitis. ZOLOFT dosage: unknown. During the same period patient was treated with WELLBUTRIN. Patient recovered.

Physician from UNITED STATES reported ZOLOFT problem on May 26, 2007. Female patient, weighting 160.1 lb, was diagnosed with depression, nausea, vomiting, increased upper airway secretion and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: bronchitis, depression, feeling abnormal, gastritis, increased upper airway secretion, tremor. ZOLOFT dosage: unknown. During the same period patient was treated with CHANTIX, METOCLOPRAMIDE, MUCINEX, THEOPHYLLINE, LIPITOR, LOTREL, ALBUTEROL. Patient was hospitalized. Patient recovered.

ZOLOFT problem was reported by a Health Professional from FRANCE on May 28, 2007. Male patient, 99 years of age, was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: rectal haemorrhage. ZOLOFT dosage: unknown. During the same period patient was treated with CIPRALAN, CREON, DAFLON, TRIATEC, PERIDYS. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported ZOLOFT problem on May 30, 2007. Female patient was diagnosed with depression and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: akathisia, asthenia, irritability. ZOLOFT dosage: DAILY DOSE:50MG. During the same period patient was treated with SOLANAX. Patient died on 04/20/2007.

ZOLOFT problem was reported by a Consumer or non-health professional from UNITED STATES on June 04, 2007. Female patient, 41 years of age, weighting 180.0 lb, was diagnosed with depression and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: mental impairment, suicide attempt. ZOLOFT dosage: unknown. During the same period patient was treated with WELLBUTRIN. Patient recovered.

Physician from JAPAN reported ZOLOFT problem on May 28, 2007. Female patient, weighting 104.7 lb, was diagnosed with depression, anxiety, personality disorder, insomnia and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: overdose, restlessness, suicide attempt. ZOLOFT dosage: DAILY DOSE:50MG. During the same period patient was treated with LEXOTAN, HIRNAMIN, PEROSPIRONE, RISPERDAL, TETRAMIDE, DORAL, MYSLEE, DALMATE. Patient recovered.

ZOLOFT problem was reported by a Consumer or non-health professional from SWEDEN on May 30, 2007. Female patient, 41 years of age, was diagnosed with depression, fatigue and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: platelet count increased, streptococcal infection. ZOLOFT dosage: unknown. During the same period patient was treated with ZOLPIDEM, DULOXETINE. Patient recovered.

Physician from CHINA reported ZOLOFT problem on May 30, 2007. Female patient, 65 years of age, was diagnosed with depression and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased, white blood cell count increased. ZOLOFT dosage: unknown. Patient recovered.

ZOLOFT problem was reported by a Physician from FRANCE on May 30, 2007. Male patient, 16 years of age, was diagnosed with depression and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: agitation, polydipsia. ZOLOFT dosage: unknown. During the same period patient was treated with ALCOHOL, CYAMEMAZINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from BRAZIL reported ZOLOFT problem on May 30, 2007. Female patient, weighting 114.6 lb, was diagnosed with depression, bipolar disorder, panic reaction, uterine haemorrhage, vaginitis bacterial, oral contraception and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: abdominal pain, abortion, alcoholism, amenorrhoea, anxiety, bipolar disorder, blood pressure decreased, blood prolactin increased, breast pain. ZOLOFT dosage: unknown. During the same period patient was treated with PROVERA, TINIDAZOLE, CLONAZEPAM, DIANE, PAROXETINE, RIVOTRIL. Patient recovered.

ZOLOFT problem was reported by a Physician from FRANCE on May 30, 2007. Male patient was diagnosed with obsessive-compulsive disorder, anxiety and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: fall, malaise, prothrombin time ratio decreased, vertigo. ZOLOFT dosage: DAILY DOSE:100MG. During the same period patient was treated with ATARAX. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZOLOFT problem on June 08, 2007. Male patient, 32 years of age, weighting 185.0 lb, was diagnosed with depression, bipolar disorder, schizophrenia and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, aggression, bipolar disorder, circadian rhythm sleep disorder, economic problem, imprisonment, mania, psychotic disorder, schizophrenia. ZOLOFT dosage: unknown. During the same period patient was treated with RISPERDAL, ABILIFY. Patient was hospitalized. Patient recovered.

ZOLOFT problem was reported by a Consumer or non-health professional from UNITED STATES on June 06, 2007. Female patient, weighting 175.0 lb, was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: arrhythmia. ZOLOFT dosage: unknown. During the same period patient was treated with VARENICLINE, VITAMIN. Patient recovered.

Consumer or non-health professional from BRAZIL reported ZOLOFT problem on May 31, 2007. Male patient, weighting 167.6 lb, was diagnosed with impulsive behaviour and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: chest pain, dry mouth, head injury, memory impairment, nightmare, sleep disorder, suffocation feeling. ZOLOFT dosage: unknown. Patient recovered.

ZOLOFT problem was reported by a Consumer or non-health professional from UNITED STATES on June 12, 2007. Female patient, 37 years of age, weighting 180.0 lb, was diagnosed with narcolepsy and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, arthritis, pain, pelvic fracture, psychotic disorder. ZOLOFT dosage: unknown. During the same period patient was treated with IONAMIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZOLOFT problem on June 11, 2007. Female patient, weighting 134.9 lb, was diagnosed with depression and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: activities of daily living impaired, disturbance in attention, intentional overdose. ZOLOFT dosage: DAILY DOSE:50MG. Patient was hospitalized. Patient recovered.

ZOLOFT problem was reported by a Physician from AUSTRALIA on June 06, 2007. Female patient was diagnosed with anxiety, panic attack and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: anger, anxiety, diarrhoea, fear, fear of disease, panic attack, self-injurious ideation. ZOLOFT dosage: DAILY DOSE:100MG. During the same period patient was treated with VALIUM, DIAZEPAM. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZOLOFT problem on June 05, 2007. Female patient, weighting 130.1 lb, was diagnosed with depression and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: agitation, bipolar disorder, disorientation, emotional distress, hallucination, movement disorder, nausea, overdose. ZOLOFT dosage: unknown. During the same period patient was treated with CHANTIX, LEXAPRO, PREMPRO. Patient recovered.

ZOLOFT problem was reported by a Physician from FRANCE on June 07, 2007. Female patient, weighting 136.7 lb, was diagnosed with depression, hypercholesterolaemia, hypertension, ischaemic stroke and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: pemphigoid. ZOLOFT dosage: unknown. During the same period patient was treated with VASTEN, DETENSIEL, LERCAN, PERINDOPRIL ERBUMINE, PLAVIX. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported ZOLOFT problem on June 09, 2007. Female patient, weighting 110.9 lb, was diagnosed with depression, anxiety, obsessive-compulsive disorder and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: asthenia, balance disorder, dizziness, fatigue, headache, lethargy, muscular weakness, myalgia, pain. ZOLOFT dosage: unknown. Patient recovered.

ZOLOFT problem was reported by a Consumer or non-health professional from JAPAN on June 15, 2007. Female patient, 45 years of age, was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: inner ear disorder. ZOLOFT dosage: DAILY DOSE:50MG. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZOLOFT problem on June 12, 2007. Female patient, child 12 years of age, was diagnosed with anxiety and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: agitation, akathisia, anxiety, completed suicide, confusional state, haemodynamic instability, hallucination, incorrect dose administered, influenza. ZOLOFT dosage: unknown. During the same period patient was treated with VERSED, CHARCOAL, ATIVAN. Patient died on 01/10/2004.

ZOLOFT problem was reported by a Physician from JAPAN on June 12, 2007. Male patient, 35 years of age, was diagnosed with bipolar i disorder, depression and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: suicidal ideation. ZOLOFT dosage: unknown. During the same period patient was treated with LIMAS, PAXIL, NITRAZEPAM, BROTIZOLAM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from AUSTRALIA reported ZOLOFT problem on June 15, 2007. Female patient, 15 years of age, was diagnosed with anxiety, depression and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: sepsis, ventricular tachycardia, vomiting. ZOLOFT dosage: unknown. During the same period patient was treated with CYCLOSPORINE, FENTANYL, MORPHINE, METHADONE. Patient was hospitalized. Patient died on 01/01/1998.

< Previous  Showing 151-225 of 700 Next >

Ask Our Patient Community about ZOLOFT

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant

Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres